JPRN-UMIN000014019已完成2 期
Phase II Study of Amrubicin and Paclitaxel in Previously Treated Lung Cancer Patients - Phase II Study of Amrubicin and Paclitaxel in Previously Treated Lung Cancer Patients
iigata Lung Cancer Treatment Group0 个研究点目标入组 20 人开始时间: 2014年5月21日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1 active concomitant malignancies,infections 2 symptomatic brain metastases 3 past history of severe allergic reactions to drugs 4 interstitial pneumonia identified by chest X-ray 5 bone metastasis or hypercalcemia required immediate treatment 6 other serious complications, such as uncontrolled angina pectoris,myocardial infarction, heart failure, uncontrolled diabetes mellitus or hypertension, uncontrolled massive pleural effusion or ascites. 7 allergie for PTX
研究者
相似试验
已完成
2 期
Paclitaxel and Epirubicin as neoadjuvant systemic treatment for locally advanced breast cancerCancer - BreastBreast cancerACTRN12611000307909The Queen Elizabeth Hospital40
进行中（未招募）
2 期
Phase II study of Paclitaxel and Epirubicin as Neoadjuvant Treatment for locally advanced Breast Cancer.Cancer - BreastBreast CancerACTRN12616000786493The Queen Elizabeth Hospital40
已完成
不适用
Phase 2 study of amrubicin in previously treated patients with malignant pleural mesotheliomaMalignant pleural mesotheliomaJPRN-UMIN000006381agasaki University Hospital32
进行中（未招募）
1 期
Study of Nab-paclitaxel and Gemcitabine in Elderly Patients with Pancreatic CancerMetastatic pancreatic cancerMedDRA version: 17.1 Level: PT Classification code 10033610 Term: Pancreatic carcinoma metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-003596-27-ESAsociación de Oncología Médica del Hospital de Cruces (ASONMEC)80
已完成
1 期
Phase 1-2 Study of Amrubicin plus Nedaplatin for Advanced Non-Small-Cell Lung Canceron-Small-Cell Lung CancerJPRN-UMIN000003282agasaki University Hospital35